Description:
Applications: Suitable for use in Western Blot. Other applications not tested.
Recommended Dilution: Western Blot: 1-3ug/ml Optimal dilutions to be determined by the researcher.
Positive Control: Jurkat lysate
Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
| Type | Isotype | Clone | Grade |
| Pab | IgG | | Affinity Purified |
|
| Size | | Storage | Shipping | Source | Host |
| 100ug | | -20°C | Blue Ice | Human | Goat |
|
| Concentration: |
| ~0.5mg/ml |
| Immunogen: |
| Synthetic peptide corresponding to DFCDPLENQPLPLGR, from the C-terminus of the protein sequence according to NP_115528. |
| Purity: |
| Purified by immunoaffinity chromatography. |
| Form |
| Supplied as a liquid in Tris saline, 0.02% sodium azide, pH7.3, 0.5% BSA. |
| Specificity: |
| Recognizes human PRAM-1. |
|
| Intended for research use only. Not for use in human, therapeutic, or diagnostic applications. |
1. Moog-Lutz C, Peterson EJ, Lutz PG, Eliason S, Cave-Riant F, Singer A, Di Gioia Y, Dmowski S, Kamens J, Cayre YE, Koretzky G. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells. J Biol Chem 2001 Jun 22;276(25):22375-81 PMID: 11301322. |
|